Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia
Research output: Contribution to journal › Article › peer-review
878Scopus
citations
Fingerprint
Dive into the research topics of 'Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia'. Together they form a unique fingerprint.